James Vaughn
2017
In 2017, James Vaughn earned a total compensation of $1.4M as Chief Commercial Officer at Genomic Health, a 15% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $141,140 |
|---|---|
| Option Awards | $625,230 |
| Salary | $408,000 |
| Stock Awards | $215,443 |
| Total | $1,389,813 |
Vaughn received $625.2K in option awards, accounting for 45% of the total pay in 2017.
Vaughn also received $141.1K in non-equity incentive plan, $408K in salary and $215.4K in stock awards.
Rankings
In 2017, James Vaughn's compensation ranked 7,370th out of 14,666 executives tracked by ExecPay. In other words, Vaughn earned more than 49.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,370 out of 14,666 | 50th |
Division Services | 1,362 out of 2,424 | 44th |
Major group Health Services | 118 out of 224 | 47th |
Industry group Medical And Dental Laboratories | 28 out of 64 | 56th |
Industry Medical Laboratories | 28 out of 64 | 56th |
Source: SEC filing on April 27, 2018.
Vaughn's colleagues
We found four more compensation records of executives who worked with James Vaughn at Genomic Health in 2017.